Pub Date : 2026-01-01DOI: 10.1016/j.soard.2025.09.003
Baraa Saad M.B.B.S. , Kenan Rahima M.B.B.S. , Mohammed M. Mourad B.Sc. , Dilip K. Vankayalapati M.B.B.S. , Omotayo Segun-Omosehin B.Sc. , Hafsa O. Sulaiman M.D. , James W.F. Burns M.B.B.S. , Hayato Nakanishi M.B.B.S., M.S. , Christian A. Than M.B.B.S., Ph.D. , Akheel A. Syed M.B.B.S., Ph.D., F.R.C.P.E. , Bilal Alkhaffaf M.B.Ch.B., Ph.D., F.R.C.S.
Long-term outcomes of Roux-en-Y gastric bypass (RYGB) in adolescents are limited. This systematic review and meta-analysis evaluates the safety and efficacy of RYGB in adolescents with obesity. A comprehensive literature search was conducted across databases, including MEDLINE, EMBASE, Cochrane, and SCOPUS up to July 2023. Included studies reported outcomes for participants younger than 21 years of age undergoing RYGB, with a minimum follow-up of 2 years. A random-effects model was used for pooled analysis. Twelve studies were included involving 522 adolescents. The mean age was 17.5 years (13-21 years), 73.6% of patients were female, and the mean follow-up was 48.4 months. Baseline body mass index (BMI) was 50.1 kg/m2. BMI reduction peaked at 1 year with an absolute reduction of 19.1 kg/m2, 36.6% total loss, and 67.7% excess BMI loss. At 5 years, absolute reduction of BMI was 19.1 kg/m2, percentage loss was 31.5%, and excess BMI loss was 70.5%. Comorbidity remission rates were 85% for dyslipidemia, 73% for hypertension, 85% for type 2 diabetes, and 68% for obstructive sleep apnea. Iron and vitamin B12 deficiency rates were greater postoperatively. The complication rate was 29.1%. RYGB in adolescents leads to significant weight loss and comorbidity resolution but carries risk of complications and requires monitoring for nutritional deficiencies. Further long-term studies are essential.
{"title":"Long-term outcomes of Roux-en-Y gastric bypass in the adolescent population: a systematic review and single-arm meta-analysis","authors":"Baraa Saad M.B.B.S. , Kenan Rahima M.B.B.S. , Mohammed M. Mourad B.Sc. , Dilip K. Vankayalapati M.B.B.S. , Omotayo Segun-Omosehin B.Sc. , Hafsa O. Sulaiman M.D. , James W.F. Burns M.B.B.S. , Hayato Nakanishi M.B.B.S., M.S. , Christian A. Than M.B.B.S., Ph.D. , Akheel A. Syed M.B.B.S., Ph.D., F.R.C.P.E. , Bilal Alkhaffaf M.B.Ch.B., Ph.D., F.R.C.S.","doi":"10.1016/j.soard.2025.09.003","DOIUrl":"10.1016/j.soard.2025.09.003","url":null,"abstract":"<div><div>Long-term outcomes of Roux-en-Y gastric bypass (RYGB) in adolescents are limited. This systematic review and meta-analysis evaluates the safety and efficacy of RYGB in adolescents with obesity. A comprehensive literature search was conducted across databases, including MEDLINE, EMBASE, Cochrane, and SCOPUS up to July 2023. Included studies reported outcomes for participants younger than 21 years of age undergoing RYGB, with a minimum follow-up of 2 years. A random-effects model was used for pooled analysis. Twelve studies were included involving 522 adolescents. The mean age was 17.5 years (13-21 years), 73.6% of patients were female, and the mean follow-up was 48.4 months. Baseline body mass index (BMI) was 50.1 kg/m<sup>2</sup>. BMI reduction peaked at 1 year with an absolute reduction of 19.1 kg/m<sup>2</sup>, 36.6% total loss, and 67.7% excess BMI loss. At 5 years, absolute reduction of BMI was 19.1 kg/m<sup>2</sup>, percentage loss was 31.5%, and excess BMI loss was 70.5%. Comorbidity remission rates were 85% for dyslipidemia, 73% for hypertension, 85% for type 2 diabetes, and 68% for obstructive sleep apnea. Iron and vitamin B12 deficiency rates were greater postoperatively. The complication rate was 29.1%. RYGB in adolescents leads to significant weight loss and comorbidity resolution but carries risk of complications and requires monitoring for nutritional deficiencies. Further long-term studies are essential.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 164-177"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The management of individuals receiving chronic anticoagulation (CAC) who are undergoing bariatric surgery presents a complex challenge, because there is a delicate balance between risks of perioperative bleeding and thromboembolic events.
Objectives
To evaluate and compare rates of bleeding, thrombotic events, and overall outcomes of patients on CAC undergoing bariatric surgery.
Setting
United States.
Methods
Data spanning 2020 to 2021 were extracted from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database, with a focus on patients who underwent primary minimally invasive bariatric surgery. A multivariable regression analysis examined 30-day outcomes for patients anticoagulated preoperatively. In addition, a propensity-matched analysis was performed comparing outcomes among patients on CAC and those without.
Results
In total 331,201 patients were analyzed, with 8428 (2.5%) receiving CAC. Propensity score matching revealed that patients on CAC exhibited greater rates of reoperations within 30 days (1.9% versus 1.3%, P < .001), overall readmissions after 30 days (7.2% versus 3.3% respectively, P < .0001), and reinterventions within 30 days (1.6% versus .9%, P < .0001) compared with patients not on preoperative CAC. Transfusion intra/postoperative and postoperative gastrointestinal tract bleeding events were elevated in the preoperative therapeutic anticoagulant group (2.2% versus .8%, P < .0001 and 1.4% versus .3%, P < .0001, respectively) compared with no preoperative CAC group.
Conclusions
Patients undergoing bariatric surgery while on preoperative CAC face significantly increased risks of adverse postoperative outcomes. Individuals requiring long-term anticoagulation should undergo careful consideration before proceeding with bariatric surgery.
背景：接受慢性抗凝治疗（CAC）的减肥手术患者的管理是一个复杂的挑战，因为围手术期出血和血栓栓塞事件的风险之间存在微妙的平衡。目的：评估和比较接受减肥手术的CAC患者的出血、血栓形成事件和总体结果。背景：美国。方法：从代谢和减肥手术认证和质量改进计划数据库中提取2020年至2021年的数据，重点关注接受初级微创减肥手术的患者。多变量回归分析检查了术前抗凝患者30天的预后。此外，进行了倾向匹配分析，比较了CAC患者和未CAC患者的结果。结果：共分析了331,201例患者，其中8428例（2.5%）接受了CAC。倾向评分匹配显示，CAC患者在30天内的再手术率（1.9%对1.3%,P < .001）、30天后的总体再入院率（7.2%对3.3%,P < .0001）和30天内的再干预率(1.6%对。9%, P < 0.0001)，与术前未行CAC的患者相比。在术前抗凝治疗组中，输血、术后和术后胃肠道出血事件均升高（2.2% vs .2%）。8%, P < 0.0001, 1.4%。3%, P < 0.0001)，与术前无CAC组比较。结论：术前行CAC的减肥手术患者术后不良预后的风险显著增加。需要长期抗凝治疗的个体在进行减肥手术前应仔细考虑。
{"title":"Impact of chronic anticoagulation on perioperative outcomes in patients undergoing minimally invasive bariatric surgery—Propensity score–matched analysis using the 2020–2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program","authors":"Elad Boaz M.D. , Pauline Aeschbacher M.D. , Noam Kahana M.D. , Nir Horesh M.D. , Emanuele Lo Menzo M.D. Ph.D., F.A.C.S. , Samuel Szomstein M.D., F.A.C.S., F.A.S.M.B.S. , Raul J. Rosenthal M.D., F.A.C.S., F.A.S.M.B.S.","doi":"10.1016/j.soard.2025.09.004","DOIUrl":"10.1016/j.soard.2025.09.004","url":null,"abstract":"<div><h3>Background</h3><div>The management of individuals receiving chronic anticoagulation (CAC) who are undergoing bariatric surgery presents a complex challenge, because there is a delicate balance between risks of perioperative bleeding and thromboembolic events.</div></div><div><h3>Objectives</h3><div>To evaluate and compare rates of bleeding, thrombotic events, and overall outcomes of patients on CAC undergoing bariatric surgery.</div></div><div><h3>Setting</h3><div>United States.</div></div><div><h3>Methods</h3><div>Data spanning 2020 to 2021 were extracted from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database, with a focus on patients who underwent primary minimally invasive bariatric surgery. A multivariable regression analysis examined 30-day outcomes for patients anticoagulated preoperatively. In addition, a propensity-matched analysis was performed comparing outcomes among patients on CAC and those without.</div></div><div><h3>Results</h3><div>In total 331,201 patients were analyzed, with 8428 (2.5%) receiving CAC. Propensity score matching revealed that patients on CAC exhibited greater rates of reoperations within 30 days (1.9% versus 1.3%, <em>P</em> < .001), overall readmissions after 30 days (7.2% versus 3.3% respectively, <em>P</em> < .0001), and reinterventions within 30 days (1.6% versus .9%, <em>P</em> < .0001) compared with patients not on preoperative CAC. Transfusion intra/postoperative and postoperative gastrointestinal tract bleeding events were elevated in the preoperative therapeutic anticoagulant group (2.2% versus .8%, <em>P</em> < .0001 and 1.4% versus .3%, <em>P</em> < .0001, respectively) compared with no preoperative CAC group.</div></div><div><h3>Conclusions</h3><div>Patients undergoing bariatric surgery while on preoperative CAC face significantly increased risks of adverse postoperative outcomes. Individuals requiring long-term anticoagulation should undergo careful consideration before proceeding with bariatric surgery.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 49-55"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.soard.2025.11.012
Kamal Abi Mosleh M.D., Hugh Babineau M.D.
{"title":"Comment on: “impact of chronic anticoagulation on perioperative outcomes in patients undergoing minimally invasive bariatric surgery - propensity score matched analysis using the 2020-2021 MBSAQIP”","authors":"Kamal Abi Mosleh M.D., Hugh Babineau M.D.","doi":"10.1016/j.soard.2025.11.012","DOIUrl":"10.1016/j.soard.2025.11.012","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 55-56"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145663149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Research indicates the prevalence of alcohol use disorder (AUD) increases following bariatric surgery. However, the evolution of alcohol drinking motives over time and the predictors of increased alcohol use postsurgery remain unclear.
Objectives
This study examined changes in alcohol consumption and drinking motives during the first 6 months after bariatric surgery, as well as psychological factors associated with increased postoperative alcohol use.
Setting
The research was conducted across four Belgian hospitals.
Methods
A prospective cohort study was carried out. Of the 298 participants who completed baseline questionnaires, 252 (84.6%) completed them 6 months postsurgery.
Results
Six months postsurgery, the prevalence of probable AUD (7.9% versus 3.2%, P < .01), and the total Alcohol Use Disorders Identification Test scores declined (z = −6.28; P < .001) in the full sample. However, a subgroup (9.1%) reported increased alcohol intake (z = −4.23; P < .001) and heightened coping-related drinking motives (z = −2.82; P < .01), a pattern not observed in the overall sample. Preoperative psychological factors (i.e., emotional regulation, experiential avoidance, emotional eating) were not significantly associated with postoperative alcohol use. However, the group with increased intake showed higher postoperative anxiety than others (H(2) = 7.12; P = .03), and was the only one in which anxiety scores did not decrease postoperatively (z = −.89, P = .37).
Conclusions
By 6 months postsurgery, a subset of individuals demonstrated increased alcohol use, coping drinking motives, and persistent high anxiety. The 6-month postoperative period may represent a key window for implementing interventions to prevent AUD development.
背景：研究表明，减肥手术后酒精使用障碍（AUD）的患病率增加。然而，随着时间的推移，饮酒动机的演变以及术后饮酒增加的预测因素仍不清楚。目的：本研究考察了减肥手术后前6个月饮酒量和饮酒动机的变化，以及与术后饮酒增加相关的心理因素。环境：这项研究在比利时的四家医院进行。方法：采用前瞻性队列研究。在298名完成基线问卷的参与者中，252名（84.6%）在术后6个月完成问卷。结果：术后6个月，整个样本中可能的AUD患病率（7.9%对3.2%,P < 0.01）和酒精使用障碍识别测试总分下降（z = -6.28; P < 0.001）。然而，一个亚组（9.1%）报告酒精摄入量增加（z = -4.23; P < .001）和应对相关饮酒动机增加（z = -2.82; P < .01），这一模式在整个样本中未观察到。术前心理因素（即情绪调节、体验性回避、情绪性进食）与术后酒精使用无显著相关。然而，摄入量增加组术后焦虑水平高于其他组(H(2) = 7.12；P = .03)，是唯一一个术后焦虑评分没有下降的患者（z = - 0.89, P = .37）。结论：术后6个月，一部分个体表现出酒精使用增加、应对饮酒动机和持续的高度焦虑。术后6个月可能是实施干预措施预防AUD发展的关键窗口期。
{"title":"Early evolution of alcohol use and drinking motives after bariatric surgery and associated factors: a prospective cohort study","authors":"Esin Er Ph.D. , Anne-Marie Etienne Ph.D. , Cécile Flahault Ph.D. , Etienne Quertemont Ph.D.","doi":"10.1016/j.soard.2025.09.013","DOIUrl":"10.1016/j.soard.2025.09.013","url":null,"abstract":"<div><h3>Background</h3><div>Research indicates the prevalence of alcohol use disorder (AUD) increases following bariatric surgery. However, the evolution of alcohol drinking motives over time and the predictors of increased alcohol use postsurgery remain unclear.</div></div><div><h3>Objectives</h3><div>This study examined changes in alcohol consumption and drinking motives during the first 6 months after bariatric surgery, as well as psychological factors associated with increased postoperative alcohol use.</div></div><div><h3>Setting</h3><div>The research was conducted across four Belgian hospitals.</div></div><div><h3>Methods</h3><div>A prospective cohort study was carried out. Of the 298 participants who completed baseline questionnaires, 252 (84.6%) completed them 6 months postsurgery.</div></div><div><h3>Results</h3><div>Six months postsurgery, the prevalence of probable AUD (7.9% versus 3.2%, <em>P</em> < .01), and the total Alcohol Use Disorders Identification Test scores declined (z = −6.28; <em>P</em> < .001) in the full sample. However, a subgroup (9.1%) reported increased alcohol intake (z = −4.23; <em>P</em> < .001) and heightened coping-related drinking motives (z = −2.82; <em>P</em> < .01), a pattern not observed in the overall sample. Preoperative psychological factors (i.e., emotional regulation, experiential avoidance, emotional eating) were not significantly associated with postoperative alcohol use. However, the group with increased intake showed higher postoperative anxiety than others (H(2) = 7.12; <em>P</em> = .03), and was the only one in which anxiety scores did not decrease postoperatively (z = −.89, <em>P</em> = .37).</div></div><div><h3>Conclusions</h3><div>By 6 months postsurgery, a subset of individuals demonstrated increased alcohol use, coping drinking motives, and persistent high anxiety. The 6-month postoperative period may represent a key window for implementing interventions to prevent AUD development.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 126-136"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.soard.2025.11.017
{"title":"Cartoon Jan 2026","authors":"","doi":"10.1016/j.soard.2025.11.017","DOIUrl":"10.1016/j.soard.2025.11.017","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Page 187"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.soard.2025.12.001
{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 22, January 2026","authors":"","doi":"10.1016/j.soard.2025.12.001","DOIUrl":"10.1016/j.soard.2025.12.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 184-186"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.soard.2025.08.024
Agustina A. Pontecorvo M.D., Jorge Cornejo M.D., Tamar Tsenteradze M.D., Steven Bowers M.D., Enrique F. Elli M.D.
Background
Adjustable gastric banding (AGB) was a widely performed bariatric surgery, but over time, sleeve gastrectomy (SG) became the most commonly performed procedure. Both AGB and SG carry the risk of weight regain, which may require conversion to Roux-en-Y gastric bypass (RYGB). However, the impact of AGB prior to SG on postoperative outcomes after conversion to RYGB remains unclear.
Objectives
The aim of this study is to compare the postoperative outcomes, including weight loss, between patients who underwent 3 bariatric procedures, including AGB, SG and finally conversion to RYGB and those who only underwent SG and conversion to RYGB.
Setting
University Hospital.
Methods
A retrospective analysis of patients who underwent SG conversion to RYGB between 2016 and 2024 was conducted. Demographics, perioperative outcomes, and weight loss were compared between patients with prior history of AGB and those without.
Results
A total of 122 patients were included, of whom 25 had AGB prior to SG conversion to RYGB. The body mass index (BMI) prior to the revision was 36.6 and 35.8kg/m2, respectively. At the 2-year follow-up, data were available for 72.2% of the total cohort. There was no significant difference in operative times (P = .77) and early and late postoperative complications (P > .05). However, patients without a history of AGB demonstrated significantly greater weight loss at 6, 12, and 24 months postoperatively. Their percentage of total weight loss (%TWL) was 15.4%, 17.9%, and 19.1%, respectively, compared to 11.7%, 12.5%, and 13.3% in patients who had undergone AGB prior to SG conversion to RYGB (P = .012).
Conclusions
Patients who underwent AGB prior to other bariatric procedures tend to experience poorer weight loss compared to those who did not have prior band.
{"title":"Does a prior conversion from adjustable gastric banding to sleeve gastrectomy impact the outcomes of subsequent conversion to Roux-en-Y gastric bypass?","authors":"Agustina A. Pontecorvo M.D., Jorge Cornejo M.D., Tamar Tsenteradze M.D., Steven Bowers M.D., Enrique F. Elli M.D.","doi":"10.1016/j.soard.2025.08.024","DOIUrl":"10.1016/j.soard.2025.08.024","url":null,"abstract":"<div><h3>Background</h3><div>Adjustable gastric banding (AGB) was a widely performed bariatric surgery, but over time, sleeve gastrectomy (SG) became the most commonly performed procedure. Both AGB and SG carry the risk of weight regain, which may require conversion to Roux-en-Y gastric bypass (RYGB). However, the impact of AGB prior to SG on postoperative outcomes after conversion to RYGB remains unclear.</div></div><div><h3>Objectives</h3><div>The aim of this study is to compare the postoperative outcomes, including weight loss, between patients who underwent 3 bariatric procedures, including AGB, SG and finally conversion to RYGB and those who only underwent SG and conversion to RYGB.</div></div><div><h3>Setting</h3><div>University Hospital.</div></div><div><h3>Methods</h3><div>A retrospective analysis of patients who underwent SG conversion to RYGB between 2016 and 2024 was conducted. Demographics, perioperative outcomes, and weight loss were compared between patients with prior history of AGB and those without.</div></div><div><h3>Results</h3><div>A total of 122 patients were included, of whom 25 had AGB prior to SG conversion to RYGB. The body mass index (BMI) prior to the revision was 36.6 and 35.8kg/m<sup>2</sup>, respectively. At the 2-year follow-up, data were available for 72.2% of the total cohort. There was no significant difference in operative times (<em>P</em> = .77) and early and late postoperative complications (<em>P</em> > .05). However, patients without a history of AGB demonstrated significantly greater weight loss at 6, 12, and 24 months postoperatively. Their percentage of total weight loss (%TWL) was 15.4%, 17.9%, and 19.1%, respectively, compared to 11.7%, 12.5%, and 13.3% in patients who had undergone AGB prior to SG conversion to RYGB (<em>P</em> = .012).</div></div><div><h3>Conclusions</h3><div>Patients who underwent AGB prior to other bariatric procedures tend to experience poorer weight loss compared to those who did not have prior band.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 76-83"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.soard.2025.08.022
Daylon A. Farias M.S. , Marc A. Ward M.D. , Brittany A. Buckmaster M.P.A.S. , Rehma Shabbir M.B.B.S. , Rachel S. Jefferies M.S. , Gerald O. Ogola Ph.D. , Santiago Quevedo B.S. , Jenifer Fang M.C.N. , Steven G. Leeds M.D.
Background
Sleeve gastrectomy is the most common bariatric procedure, and leaks from the staple line is a difficult complication to manage. Investigation into optimal nutritional support during this management is poorly studied.
Objective
The purpose of this study was to determine which supplemental nutritional group, enteral or parenteral, achieved superior nutritional outcomes.
Setting
Quaternary care center.
Methods
An IRB approved, retrospective review of a prospectively maintained database, identified patients who had a sleeve gastrectomy leak. We included patients who underwent endoluminal vacuum therapy for leak management. Patients were assigned to 3 cohorts based on their nutritional support: enteral, parenteral, or both. Primary endpoints included nutrition days, % kilocalories met, and % protein met. Secondary endpoints focused on albumin levels.
Results
A total of 28 patients (7 male, 21 female) met the inclusion criteria for the study. Five patients received enteral nutrition, 11 patients received parenteral nutrition, and 12 patients received both. Patients who received parenteral nutrition met their daily kcal and protein goals unlike patients who received enteral nutrition (97.4%% versus 55.4%, P < .01, and 105.9% versus 58.7%, P < .01, respectively). Patients who received parenteral nutrition showed an upward trend with their serum albumin levels from day 0 (3.24, 95% CI, 2.93-3.54) to Day 20 (3.34, 95%CI, 2.96-3.72).
Conclusion
Parenteral nutrition met superior goals compared to enteral nutrition. Additionally, parenteral nutrition serum albumin levels were consistently higher than enteral nutrition. Patients undergoing endoscopic therapy for gastric sleeve leak management may experience greater benefits with parenteral nutrition.
{"title":"Achieving optimal nutritional goals in management of patients with sleeve gastrectomy leaks with endoluminal vacuum therapy","authors":"Daylon A. Farias M.S. , Marc A. Ward M.D. , Brittany A. Buckmaster M.P.A.S. , Rehma Shabbir M.B.B.S. , Rachel S. Jefferies M.S. , Gerald O. Ogola Ph.D. , Santiago Quevedo B.S. , Jenifer Fang M.C.N. , Steven G. Leeds M.D.","doi":"10.1016/j.soard.2025.08.022","DOIUrl":"10.1016/j.soard.2025.08.022","url":null,"abstract":"<div><h3>Background</h3><div>Sleeve gastrectomy is the most common bariatric procedure, and leaks from the staple line is a difficult complication to manage. Investigation into optimal nutritional support during this management is poorly studied.</div></div><div><h3>Objective</h3><div>The purpose of this study was to determine which supplemental nutritional group, enteral or parenteral, achieved superior nutritional outcomes.</div></div><div><h3>Setting</h3><div>Quaternary care center.</div></div><div><h3>Methods</h3><div>An IRB approved, retrospective review of a prospectively maintained database, identified patients who had a sleeve gastrectomy leak. We included patients who underwent endoluminal vacuum therapy for leak management. Patients were assigned to 3 cohorts based on their nutritional support: enteral, parenteral, or both. Primary endpoints included nutrition days, % kilocalories met, and % protein met. Secondary endpoints focused on albumin levels.</div></div><div><h3>Results</h3><div>A total of 28 patients (7 male, 21 female) met the inclusion criteria for the study. Five patients received enteral nutrition, 11 patients received parenteral nutrition, and 12 patients received both. Patients who received parenteral nutrition met their daily kcal and protein goals unlike patients who received enteral nutrition (97.4%% versus 55.4%, <em>P</em> < .01, and 105.9% versus 58.7%, <em>P</em> < .01, respectively). Patients who received parenteral nutrition showed an upward trend with their serum albumin levels from day 0 (3.24, 95% CI, 2.93-3.54) to Day 20 (3.34, 95%CI, 2.96-3.72).</div></div><div><h3>Conclusion</h3><div>Parenteral nutrition met superior goals compared to enteral nutrition. Additionally, parenteral nutrition serum albumin levels were consistently higher than enteral nutrition. Patients undergoing endoscopic therapy for gastric sleeve leak management may experience greater benefits with parenteral nutrition.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 1","pages":"Pages 40-46"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-31DOI: 10.1016/j.soard.2025.12.005
Marius Nedelcu M.D., Marc Danan M.D., Anamaria Nedelcu M.D.
{"title":"Paired editorial comment: revisional bariatric surgery in the elderly: a comprehensive review of the safety and efficacy profile","authors":"Marius Nedelcu M.D., Marc Danan M.D., Anamaria Nedelcu M.D.","doi":"10.1016/j.soard.2025.12.005","DOIUrl":"10.1016/j.soard.2025.12.005","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 3","pages":"Pages 378-379"},"PeriodicalIF":3.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-31DOI: 10.1016/j.soard.2025.12.002
Megan Jenkins M.D., F.A.C.S., F.A.S.M.B.S.
{"title":"Comment on: a history of bariatric surgery is associated with a shorter length of stay for patients undergoing renal transplant","authors":"Megan Jenkins M.D., F.A.C.S., F.A.S.M.B.S.","doi":"10.1016/j.soard.2025.12.002","DOIUrl":"10.1016/j.soard.2025.12.002","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 3","pages":"Pages 376-377"},"PeriodicalIF":3.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146192974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号